These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 27983526

  • 21. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
    Son MS, Jang MJ, Jeon YJ, Kim WH, Kwon CI, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK.
    Gene; 2013 Jul 25; 524(2):156-60. PubMed ID: 23632240
    [Abstract] [Full Text] [Related]

  • 22. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
    Zhang J, Huang X, Xiao J, Yang Y, Zhou Y, Wang X, Liu Q, Yang J, Wang M, Qiu L, Zheng Y, Zhang P, Li J, Wang Y, Wei Q, Jin L, Wang J, Wang M.
    PLoS One; 2014 Jul 25; 9(6):e100055. PubMed ID: 24945256
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
    Liu P, Zhuo ZJ, Zhu J, Yang Z, Xin Y, Li S, Li L, Li Y, Wang H, He J.
    J Gene Med; 2020 Jul 25; 22(7):e3182. PubMed ID: 32166848
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y, Pu R, Han X, Zhao J, Zhang Y, Zhang Q, Yin J, Xie J, Shen Q, Deng Y, Ding Y, Li W, Li J, Zhang H, Cao G.
    PLoS One; 2013 Jul 25; 8(3):e58564. PubMed ID: 23516510
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer.
    Yu K.
    Cell Physiol Biochem; 2017 Jul 25; 43(3):1235-1246. PubMed ID: 28977792
    [Abstract] [Full Text] [Related]

  • 35. Analysis of association of potentially functional genetic variants within genes encoding miR-34b/c, miR-378 and miR-143/145 with prostate cancer in Serbian population.
    Kotarac N, Dobrijevic Z, Matijasevic S, Savic-Pavicevic D, Brajuskovic G.
    EXCLI J; 2019 Jul 25; 18():515-529. PubMed ID: 31423132
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
    Xu B, Zhu Y, Tang Y, Zhang Z, Wen Q.
    Med Sci Monit; 2018 Oct 04; 24():7057-7071. PubMed ID: 30286050
    [Abstract] [Full Text] [Related]

  • 39. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.
    Yin J, Wang X, Zheng L, Shi Y, Wang L, Shao A, Tang W, Ding G, Liu C, Liu R, Chen S, Gu H.
    PLoS One; 2013 Oct 04; 8(11):e80570. PubMed ID: 24260422
    [Abstract] [Full Text] [Related]

  • 40. A causal role for circulating miR-34b in osteosarcoma.
    Tian Q, Jia J, Ling S, Liu Y, Yang S, Shao Z.
    Eur J Surg Oncol; 2014 Jan 04; 40(1):67-72. PubMed ID: 24063968
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.